解决心衰患者治疗中的健康社会决定因素：美国心脏协会的科学声明

2020-07-08 美国心脏协会 Circulation . 2020 Jun 2;141(22):e841-e863. doi: 10.1161/CIR.0000000000000767

心力衰竭是一种影响650万美国人的临床综合征，估计每年有55万新病例被诊断出来。心力衰竭管理的复杂性因经历健康的社会决定因素(SDOH)下游不利影响的患者数量而变得更为复杂。

中文标题：

英文标题：

Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2020-07-08

简要介绍：

心力衰竭是一种影响650万美国人的临床综合征，估计每年有55万新病例被诊断出来。心力衰竭管理的复杂性因经历健康的社会决定因素(SDOH)下游不利影响的患者数量而变得更为复杂。

这些患者的医疗可及性较差，因而随着时间的推移，更有可能出现不良的心力衰竭后果。许多患者面临与复杂的慢性疾病管理费用相关的额外挑战，且必须就自己的健康做出艰难的决定，特别是在用药费用和医疗预约与基本食品和住房需求不一致的情况下。

这一科学声明总结了健康的社会决定因素（SDOH）和了解其对心力衰竭患者影响的重要知识的现状。具体来说，本文件包括健康的社会决定因素（SDOH）的定义、医务人员能力和SDOH评估工具，并解决以下问题

(1)指导医务人员解决健康的社会决定因素（SDOH）的模型或框架是什么？

(2)影响医疗服务的健康的社会决定因素（SDOH）是什么？针对这些影响心力衰竭患者治疗和结果的社会决定因素的干预措施是什么?

(3)医务人员有哪些解决影响心力衰竭患者医疗问题的健康的决定因素（SDOH）的机会?

本文还包括了一个案例分析，该案例强调了跨专业团队为解决和减轻SDOH对一位医疗服务欠缺的心力衰竭患者的影响所做出的努力。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=6b58a1c0020060c1, title=解决心衰患者治疗中的健康社会决定因素：美国心脏协会的科学声明, enTitle=Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2020 Jun 2;141(22):e841-e863. doi: 10.1161/CIR.0000000000000767, authorId=0, author=, summary=心力衰竭是一种影响650万美国人的临床综合征，估计每年有55万新病例被诊断出来。心力衰竭管理的复杂性因经历健康的社会决定因素(SDOH)下游不利影响的患者数量而变得更为复杂。, cover=, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Wed Jul 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=心力衰竭是一种影响650万美国人的临床综合征，估计每年有55万新病例被诊断出来。心力衰竭管理的复杂性因经历健康的社会决定因素(SDOH)下游不利影响的患者数量而变得更为复杂。 这些患者的医疗可及性较差，因而随着时间的推移，更有可能出现不良的心力衰竭后果。许多患者面临与复杂的慢性疾病管理费用相关的额外挑战，且必须就自己的健康做出艰难的决定，特别是在用药费用和医疗预约与基本食品和住房需求不一致的情况下。 这一科学声明总结了健康的社会决定因素（SDOH）和了解其对心力衰竭患者影响的重要知识的现状。具体来说，本文件包括健康的社会决定因素（SDOH）的定义、医务人员能力和SDOH评估工具，并解决以下问题 (1)指导医务人员解决健康的社会决定因素（SDOH）的模型或框架是什么？ (2)影响医疗服务的健康的社会决定因素（SDOH）是什么？针对这些影响心力衰竭患者治疗和结果的社会决定因素的干预措施是什么? (3)医务人员有哪些解决影响心力衰竭患者医疗问题的健康的决定因素（SDOH）的机会? 本文还包括了一个案例分析，该案例强调了跨专业团队为解决和减轻SDOH对一位医疗服务欠缺的心力衰竭患者的影响所做出的努力。, tagList=[TagDto(tagId=448, tagName=心衰), TagDto(tagId=28148, tagName=社会决定因素)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1928, appHits=227, showAppHits=0, pcHits=419, showPcHits=1701, likes=2, shares=20, comments=6, approvalStatus=1, publishedTime=Mon Nov 02 13:57:51 CST 2020, publishedTimeString=2020-07-08, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Mon Nov 02 13:57:32 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 23:48:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])

66.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=902175, encodeId=9b5c9021e577, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Wed Nov 25 14:48:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897842, encodeId=bce889e842ab, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33325422284, createdName=ms2000001998520985, createdTime=Sun Nov 08 23:07:04 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896666, encodeId=afcd8966660a, content=XXueXXuexXXuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04ab5431435, createdName=ms2000001853499034, createdTime=Tue Nov 03 17:00:32 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896617, encodeId=d74a89661ead, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Tue Nov 03 15:28:19 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896260, encodeId=868389626087, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 02 14:04:12 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
2020-11-25 1281668446

谢谢分享

67 0
[GetPortalCommentsPageByObjectIdResponse(id=902175, encodeId=9b5c9021e577, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Wed Nov 25 14:48:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897842, encodeId=bce889e842ab, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33325422284, createdName=ms2000001998520985, createdTime=Sun Nov 08 23:07:04 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896666, encodeId=afcd8966660a, content=XXueXXuexXXuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04ab5431435, createdName=ms2000001853499034, createdTime=Tue Nov 03 17:00:32 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896617, encodeId=d74a89661ead, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Tue Nov 03 15:28:19 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896260, encodeId=868389626087, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 02 14:04:12 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
2020-11-08 ms2000001998520985

厉害

84 0
[GetPortalCommentsPageByObjectIdResponse(id=902175, encodeId=9b5c9021e577, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Wed Nov 25 14:48:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897842, encodeId=bce889e842ab, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33325422284, createdName=ms2000001998520985, createdTime=Sun Nov 08 23:07:04 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896666, encodeId=afcd8966660a, content=XXueXXuexXXuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04ab5431435, createdName=ms2000001853499034, createdTime=Tue Nov 03 17:00:32 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896617, encodeId=d74a89661ead, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Tue Nov 03 15:28:19 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896260, encodeId=868389626087, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 02 14:04:12 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
2020-11-03 ms2000001853499034

XXueXXuexXXuexi

91 0
[GetPortalCommentsPageByObjectIdResponse(id=902175, encodeId=9b5c9021e577, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Wed Nov 25 14:48:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897842, encodeId=bce889e842ab, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33325422284, createdName=ms2000001998520985, createdTime=Sun Nov 08 23:07:04 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896666, encodeId=afcd8966660a, content=XXueXXuexXXuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04ab5431435, createdName=ms2000001853499034, createdTime=Tue Nov 03 17:00:32 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896617, encodeId=d74a89661ead, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Tue Nov 03 15:28:19 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896260, encodeId=868389626087, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 02 14:04:12 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
2020-11-03 咻凡

学习学习！

90 0
[GetPortalCommentsPageByObjectIdResponse(id=902175, encodeId=9b5c9021e577, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4af62771678, createdName=1281668446, createdTime=Wed Nov 25 14:48:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897842, encodeId=bce889e842ab, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33325422284, createdName=ms2000001998520985, createdTime=Sun Nov 08 23:07:04 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896666, encodeId=afcd8966660a, content=XXueXXuexXXuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04ab5431435, createdName=ms2000001853499034, createdTime=Tue Nov 03 17:00:32 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896617, encodeId=d74a89661ead, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Tue Nov 03 15:28:19 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896260, encodeId=868389626087, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 02 14:04:12 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
2020-11-02 1209e435m98(暂无昵称)

学习了，谢谢分享

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

解决心衰患者治疗中的健康社会决定因素：美国心脏协会的科学声明

相关指南

科室

工具

服务